Methylene blue modulates functional connectivity in the human brain

Brain Imaging and Behavior

Volumn 11, Issue 3, 2017, Pages 640-648

  Rodriguez, Pavel ^a   Singh, Amar P ^a   Malloy, Kristen E ^a   Zhou, Wei ^a   Barrett, Douglas W ^b   Franklin, Crystal G ^a   Altmeyer, Wilson B ^a   Gutierrez, Juan E ^a   Li, Jinqi ^a   Heyl, Betty L ^a   Lancaster, Jack L ^a   Gonzalez Lima, F ^b   Duong, Timothy Q ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Default mode network; Evoked response; Functional connectivity; Methylene blue; Multimodal fMRI

Indexed keywords

METHYLENE BLUE; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; BOLD SIGNAL; BRAIN; BRAIN BLOOD FLOW; CONTROLLED STUDY; DEFAULT MODE NETWORK; DRUG MECHANISM; FEMALE; FUNCTIONAL CONNECTIVITY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; LOW DRUG DOSE; MALE; MEMORY; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PERCEPTION; PRIORITY JOURNAL; SALIENCE NETWORK; SINGLE DRUG DOSE; TASK POSITIVE NETWORK; VISUOMOTOR COORDINATION; BRAIN CIRCULATION; BRAIN MAPPING; DIAGNOSTIC IMAGING; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; MOTOR ACTIVITY; NERVE TRACT; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REST; VISION;

ADMINISTRATION, ORAL; ADULT; BRAIN; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHYLENE BLUE; MOTOR ACTIVITY; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS; PSYCHOTROPIC DRUGS; REST; VISUAL PERCEPTION;

EID: 84960339078     PISSN: 19317557     EISSN: 19317565     Source Type: Journal    
DOI: 10.1007/s11682-016-9541-6     Document Type: Article

References (42)

1. Bruchey, A. K., & Gonzalez-Lima, F. (2008). Behavioral, physiological and biochemical hormetic responses to the autoxidizable dye methylene blue. American Journal of Pharmacology and Toxicology, 3(1), 72–79. doi:10.3844/ajptsp.2008.72.79.
2. Callaway, N. L., Riha, P. D., Wrubel, K. M., McCollum, D., & Gonzalez-Lima, F. (2002). Methylene blue restores spatial memory retention impaired by an inhibitor of cytochrome oxidase in rats. Neuroscience Letters, 332(2), 83–86. doi:10.1016/S0304-3940(02)00827-3.
3. Clifton 2nd, J., & Leikin, J. B. (2003). Methylene blue. American Journal of Therapeutics, 10(4), 289–291. doi:10.1097/00045391-200307000-00009.
4. Fox, M. D., Snyder, A. Z., Vincent, J. L., Corbetta, M., Van Essen, D. C., & Raichle, M. E. (2005). The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proceedings of the National Academy of Sciences of the United States of America, 102(27), 9673–9678. doi:10.1073/Pnas.0504136102.
5. Fox, K. C., Spreng, R. N., Ellamil, M., Andrews-Hanna, J. R., & Christoff, K. (2015). The wandering brain: meta-analysis of functional neuroimaging studies of mind-wandering and related spontaneous thought processes. NeuroImage, 111, 611–621. doi:10.1016/j.neuroimage.2015.02.039.
6. Geier, C. F., Garver, K., Terwilliger, R., & Luna, B. (2009). Development of working memory maintenance. Journal of Neurophysiology, 101(1), 84–99. doi:10.1152/jn.90562.2008.
7. Gläscher, J., & Gitelman, D. (2008). Contrast weights in flexible factorial design with multiple groups of subjects. < http://www.sbirc.ed.ac.uk/cyril/download/Contrast_Weighting_Glascher_Gitelman_2008.pdf> Accessed Feb. 2016.
8. Gonzalez-Lima, F., & Bruchey, A. K. (2004). Extinction memory improvement by the metabolic enhancer methylene blue. Learning & Memory, 11(5), 633–640. doi:10.1101/lm.82404.
9. Greicius, M. D., Flores, B. H., Menon, V., Glover, G. H., Solvason, H. B., Kenna, H., et al. (2007). Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biological Psychiatry, 62(5), 429–437. doi:10.1016/j.biopsych.2006.09.020.
10. Huang, S., Du, F., Shih, Y. Y., Shen, Q., Gonzalez-Lima, F., & Duong, T. Q. (2013). Methylene blue potentiates stimulus-evoked fMRI responses and cerebral oxygen consumption during normoxia and hypoxia. NeuroImage, 72, 237–242. doi:10.1016/j.neuroimage.2013.01.027.
11. Jeneson, A., & Squire, L. R. (2012). Working memory, long-term memory, and medial temporal lobe function. Learning & Memory, 19(1), 15–25. doi:10.1101/lm.024018.111.
12. Jiang, Z., Watts, L. T., Huang, S. L., Shen, Q., Rodriguez, P., Chen, C. H., et al. (2015). The Effects of Methylene Blue on Autophagy and Apoptosis in MRI-Defined Normal Tissue, Ischemic Penumbra and Ischemic Core. PloS One, 10(6). doi:10.1371/journal.pone.0131929.
13. Lehmann, M., Madison, C. M., Ghosh, P. M., Seeley, W. W., Mormino, E., Greicius, M. D., et al. (2013). Intrinsic connectivity networks in healthy subjects explain clinical variability in Alzheimer’s disease. Proceedings of the National Academy of Sciences of the United States of America, 110(28), 11606–11611. doi:10.1073/pnas.1221536110.
14. Liddle, E. B., Hollis, C., Batty, M. J., Groom, M. J., Totman, J. J., Liotti, M., et al. (2011). Task-related default mode network modulation and inhibitory control in ADHD: effects of motivation and methylphenidate. Journal of Child Psychology and Psychiatry, 52(7), 761–771. doi:10.1111/J.1469-7610.2010.02333.X.
15. Lin, A. L., Poteet, E., Du, F., Gourav, R. C., Liu, R., Wen, Y., et al. (2012). Methylene blue as a cerebral metabolic and hemodynamic enhancer. PloS One, 7(10), e46585. doi:10.1371/journal.pone.0046585.
16. Maldjian, J. A., Laurienti, P. J., Kraft, R. A., & Burdette, J. H. (2003). An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. NeuroImage, 19(3), 1233–1239. doi:10.1016/s1053-8119(03)00169-1.
17. Markett, S., Reuter, M., Montag, C., Voigt, G., Lachmann, B., Rudorf, S., et al. (2014). Assessing the function of the fronto-parietal attention network: insights from resting-state fMRI and the attentional network test. Human Brain Mapping, 35(4), 1700–1709. doi:10.1002/hbm.22285.
18. Martinez, J. L., Jensen, R. A., Vasquez, B. J., McGuinness, T., & McGaugh, J. L. (1978). Methylene-blue alters retention of inhibitory avoidance responses. Physiological Psychology, 6(3), 387–390. doi:10.3758/bf03326744.
19. McIntosh, A. R. (2000). Towards a network theory of cognition. Neural Networks, 13(8–9), 861–870. doi:10.1016/s0893-6080(00)00059-9.
20. McIntosh, A. R., & Gonzalez-Lima, F. (1995). Functional network interactions between parallel auditory pathways during Pavlovian conditioned inhibition. Brain Research, 683(2), 228–241. doi:10.1016/0006-8993(95)00378-4.
21. Minzenberg, M. J., Yoon, J. H., & Carter, C. S. (2011). Modafinil modulation of the default mode network. Psychopharmacology, 215(1), 23–31. doi:10.1007/S00213-010-2111-5.
22. Pamplona, G. S., Santos Neto, G. S., Rosset, S. R., Rogers, B. P., & Salmon, C. E. (2015). Analyzing the association between functional connectivity of the brain and intellectual performance. Frontiers in Human Neuroscience, 9, 61. doi:10.3389/fnhum.2015.00061.
23. Pankevich, D. E., Altevogt, B. M., Dunlop, J., Gage, F. H., & Hyman, S. E. (2014). Improving and accelerating drug development for nervous system disorders. Neuron, 84(3), 546–553. doi:10.1016/j.neuron.2014.10.007.
24. Peter, C., Hongwan, D., Kupfer, A., & Lauterburg, B. H. (2000). Pharmacokinetics and organ distribution of intravenous and oral methylene blue. European Journal of Clinical Pharmacology, 56(3), 247–250. doi:10.1007/s002280000124.
25. Raichle, M. E. (2015). The Brain’s default mode network. Annual Review of Neuroscience, 38, 433–447. doi:10.1146/annurev-neuro-071013-014030.
26. Riha, P. D., Rojas, J. C., & Gonzalez-Lima, F. (2011). Beneficial network effects of methylene blue in an amnestic model. NeuroImage, 54(4), 2623–2634. doi:10.1016/j.neuroimage.2010.11.023.
27. Rodriguez, P., Jiang, Z., Huang, S., Shen, Q., & Duong, T. Q. (2014). Methylene blue treatment delays progression of perfusion-diffusion mismatch to infarct in permanent ischemic stroke. Brain Research, 1588, 144–149.
28. Rojas, J. C., Bruchey, A. K., & Gonzalez-Lima, F. (2012). Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Progress in Neurobiology, 96(1), 32–45. doi:10.1016/j.pneurobio.2011.10.007.
29. Scheindlin, S. (2008). Something old.. something blue. Molecular Interventions, 8(6), 268–273, doi:10.1124/mi.8.6.1.
30. Scott, A., & Hunter Jr., F. E. (1966). Support of thyroxine-induced swelling of liver mitochondria by generation of high energy intermediates at any one of three sites in electron transport. The Journal of Biological Chemistry, 241(5), 1060–1066.
31. Shen, Q., Du, F., Huang, S., Rodriguez, P., Watts, L. T., & Duong, T. Q. (2013). Neuroprotective efficacy of methylene blue in ischemic stroke: an MRI study. PloS One, 8(11), e79833. doi:10.1371/journal.pone.0079833.
32. Shirer, W. R., Ryali, S., Rykhlevskaia, E., Menon, V., & Greicius, M. D. (2012). Decoding subject-driven cognitive states with whole-brain connectivity patterns. Cerebral Cortex, 22(1), 158–165. doi:10.1093/Cercor/Bhr099.
33. Telch, M. J., Bruchey, A. K., Rosenfield, D., Cobb, A. R., Smits, J., Pahl, S., et al. (2014). Effects of post-session administration of methylene blue on fear extinction and contextual memory in adults with claustrophobia. The American Journal of Psychiatry, 171(10), 1091–1098. doi:10.1176/appi.ajp.2014.13101407.
34. Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., et al. (2002). Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage, 15(1), 273–289. doi:10.1006/nimg.2001.0978.
35. Walter-Sack, I., Rengelshausen, J., Oberwittler, H., Burhenne, J., Mueller, O., Meissner, P., et al. (2009). High absolute bioavailability of methylene blue given as an aqueous oral formulation. European Journal of Clinical Pharmacology, 65(2), 179–189. doi:10.1007/s00228-008-0563-x.
36. Wang, Z., Aguirre, G. K., Rao, H., Wang, J., Fernandez-Seara, M. A., Childress, A. R., et al. (2008). Empirical optimization of ASL data analysis using an ASL data processing toolbox: ASLtbx. Magnetic Resonance Imaging, 26(2), 261–269. doi:10.1016/j.mri.2007.07.003.
37. Watts, L. T., Long, J. A., Chemello, J., Van Koughnet, S., Fernandez, A., Huang, S., et al. (2014). Methylene blue is neuroprotective against mild traumatic brain injury. Journal of Neurotrauma, 31(11), 1063–1071. doi:10.1089/neu.2013.3193.
38. Watts, L. T., Long, J. A., Boggs, R. C., Manga, H., Huang, S., Shen, Q., et al. (2015). Delayed methylene blue improves lesion volume, multi-parametric quantitative magnetic resonance imaging measurements, and behavioral outcome after traumatic brain injury. Journal of Neurotrauma. doi:10.1089/neu.2015.3904.
39. Whitfield-Gabrieli, S., & Nieto-Castanon, A. (2012). Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connectivity, 2(3), 125–141. doi:10.1089/brain.2012.0073.
40. Witt, S. T., Laird, A. R., & Meyerand, M. E. (2008). Functional neuroimaging correlates of finger-tapping task variations: an ALE meta-analysis. NeuroImage, 42(1), 343–356. doi:10.1016/j.neuroimage.2008.04.025.
41. Wrubel, K. M., Riha, P. D., Maldonado, M. A., McCollum, D., & Gonzalez-Lima, F. (2007). The brain metabolic enhancer methylene blue improves discrimination learning in rats. Pharmacology, Biochemistry, and Behavior, 86(4), 712–717. doi:10.1016/J.Pbb.2007.02.018.
42. Zhang, X., Rojas, J. C., & Gonzalez-Lima, F. (2006). Methylene blue prevents neurodegeneration caused by rotenone in the retina. Neurotoxicity Research, 9(1), 47–57. doi:10.1007/bf03033307.